Assistant Attending, Myeloma Service
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Dr. Urvi A. Shah, MD, MS is an Assistant Attending at Memorial Sloan Kettering Cancer Center. She is board certified in Internal Medicine, Hematology and Medical Oncology and received a Master of Science degree in Clinical and Translational Cancer Research. Her research interests include modifiable risk factors (diet, metabolism, microbiome) in cancer. She completed the first pilot nutrition trial in plasma cell disorders to date (NUTRIVENTION) and has 3 other dietary trials enrolling. Dr. Shah has been supported by career development awards (National Cancer Institute [NCI] K12, International Myeloma Society and American Society of Hematology [ASH] Scholar) and research awards (ASH CRTI, ECOG ACRIN Young Investigator Translational Research, Henry Moses, Celgene Future Leaders in Hematology, NCI Early Investigator Advancement Program, Clinical Cancer Research Early Career, ASH David M. Goldenberg CRTI). She has published papers in prominent journals and has been an invited speaker and chair.
Disclosure information not submitted.
In-Person Workshop: Lifestyle Medicine in Cancer Care: Ready for Prime Time?
Sunday, November 16, 2025
9:00 AM – 12:00 PM CT
Bridging the Gap Between the Forest and Trees: LM in Cancer Risk Reduction to Improve Outcomes.
Tuesday, November 18, 2025
10:45 AM – 11:45 AM CT